Title | 4‐month disease control rate |
Number of Patients Screened | 28 |
Number of Patients Enrolled | 26 |
Number of Patients Evaluable for Toxicity | 25 |
Number of Patients Evaluated for Efficacy | 25 |
Evaluation Method | RECIST 1.1 |
Response Assessment OTHER | n = 8 (32%) |